help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2007-1021
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
149/4/1646    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Son, B.-K.
Right arrow Articles by Ouchi, Y.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Son, B.-K.
Right arrow Articles by Ouchi, Y.
Endocrinology Vol. 149, No. 4 1646-1653
Copyright © 2008 by The Endocrine Society

Adiponectin Antagonizes Stimulatory Effect of Tumor Necrosis Factor-{alpha} on Vascular Smooth Muscle Cell Calcification: Regulation of Growth Arrest-Specific Gene 6-Mediated Survival Pathway by Adenosine 5'-Monophosphate-Activated Protein Kinase

Bo-Kyung Son, Masahiro Akishita, Katsuya Iijima, Koichi Kozaki, Koji Maemura, Masato Eto and Yasuyoshi Ouchi

Department of Geriatric Medicine (B.-K.S., M.A., K.I., M.E., Y.O.), the Department of Cardiovascular Medicine (K.M.), Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan; and the Department of Geriatric Medicine (K.K.), School of Medicine, The University of Kyorin, Tokyo 181-8611, Japan

Address all correspondence and requests for reprints to: Masahiro Akishita, M.D., Ph.D., Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. E-mail: akishita-tky{at}umin.ac.jp.

Adiponectin exhibits diverse protective effects against atherogenesis and antagonizes many effects of TNF{alpha}. Here, we investigated the effect of adiponectin and TNF{alpha} on vascular calcification, a critical event in the development and progression of vascular disease. In human aortic smooth muscle cells (HASMC), TNF{alpha} augmented inorganic phosphate (Pi)-induced calcification, whereas adiponectin significantly suppressed it and abolished the stimulatory effect of TNF{alpha} in a concentration-dependent manner. Similarly, adiponectin ameliorated the accelerating effect of TNF{alpha} on Pi-induced apoptosis, the essential process of HASMC calcification. Furthermore, these effects of TNF{alpha} and adiponectin were associated with AMP-activated protein kinase (AMPK)-dependent growth arrest-specific gene 6 (Gas6) expression and Akt signaling. The AMPK activator, 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR), induced phosphorylation of AMPK and significantly inhibited Pi-induced calcification in HASMC. Conversely, pharmacological inhibition of AMPK by compound C blocked both AMPK activation and the inhibitory effect of adiponectin on calcification, providing evidence that AMPK plays a regulatory role in vascular calcification. Reporter assay revealed that adiponectin restored Gas6 promoter activity decreased by TNF{alpha}, and the effect of adiponectin was abrogated by compound C. These results demonstrate that adiponectin antagonizes the stimulatory effect of TNF{alpha} on vascular calcification by restoration of the AMPK-dependent Gas6-mediated survival pathway.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society